OA12608A - Process for the isolation of crystalline imiponem. - Google Patents

Process for the isolation of crystalline imiponem. Download PDF

Info

Publication number
OA12608A
OA12608A OA1200300302A OA1200300302A OA12608A OA 12608 A OA12608 A OA 12608A OA 1200300302 A OA1200300302 A OA 1200300302A OA 1200300302 A OA1200300302 A OA 1200300302A OA 12608 A OA12608 A OA 12608A
Authority
OA
OAPI
Prior art keywords
water
organic solvent
imipenem
daim
mixture
Prior art date
Application number
OA1200300302A
Other languages
English (en)
Inventor
Ram Chander Aryan
Yatendra Kumar
Bishwa Prakash Rai
Neera Tewari
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of OA12608A publication Critical patent/OA12608A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
OA1200300302A 2001-05-18 2002-05-20 Process for the isolation of crystalline imiponem. OA12608A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN595DE2001 2001-05-18

Publications (1)

Publication Number Publication Date
OA12608A true OA12608A (en) 2006-06-08

Family

ID=11097062

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300302A OA12608A (en) 2001-05-18 2002-05-20 Process for the isolation of crystalline imiponem.

Country Status (17)

Country Link
US (1) US7241885B2 (cs)
EP (1) EP1395588A4 (cs)
JP (1) JP2005514323A (cs)
KR (1) KR20040010649A (cs)
CN (1) CN1522255A (cs)
AR (1) AR036018A1 (cs)
BR (1) BR0209844A (cs)
CA (1) CA2447673A1 (cs)
CZ (1) CZ20033351A3 (cs)
HU (1) HUP0501093A2 (cs)
MX (1) MXPA03010548A (cs)
NO (1) NO20035137D0 (cs)
OA (1) OA12608A (cs)
PL (1) PL373527A1 (cs)
SK (1) SK15092003A3 (cs)
WO (1) WO2002094773A2 (cs)
ZA (1) ZA200309288B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462712B2 (en) * 2001-05-18 2008-12-09 Ranbaxy Laboratories Limited Process for the preparation of imipenem
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
EA200400682A1 (ru) * 2001-11-16 2004-10-28 Рэнбакси Лабораториз Лимитед Способ получения кристаллического имипенема
WO2009047604A1 (en) * 2007-10-08 2009-04-16 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN103524508B (zh) * 2013-09-02 2016-03-30 上海龙翔生物医药开发有限公司 一种亚胺培南一水合物的结晶方法
CN108623598A (zh) * 2018-05-21 2018-10-09 重庆天地药业有限责任公司 一种亚胺培南中间体及亚胺培南的制备方法
CN113135916A (zh) * 2020-01-20 2021-07-20 鲁南制药集团股份有限公司 一种亚胺培南制备工艺的除钯方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138433A (en) * 1975-06-26 1979-02-06 Hoechst Aktiengesellschaft Process for preparing 1,2-oxa-phospholanes
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4081455A (en) * 1976-06-02 1978-03-28 Pfizer Inc. 6-Amino-2,2-dimethyl-3-cyanopenams
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4374772A (en) * 1981-03-19 1983-02-22 Merck & Co., Inc. Process for the preparation of N-formimidoyl thienamycin and reagents therefor
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (cs) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
EA200400682A1 (ru) * 2001-11-16 2004-10-28 Рэнбакси Лабораториз Лимитед Способ получения кристаллического имипенема

Also Published As

Publication number Publication date
SK15092003A3 (sk) 2004-09-08
CN1522255A (zh) 2004-08-18
WO2002094773A3 (en) 2003-10-16
WO2002094773A2 (en) 2002-11-28
CZ20033351A3 (cs) 2007-12-27
EP1395588A4 (en) 2004-09-15
US7241885B2 (en) 2007-07-10
PL373527A1 (en) 2005-09-05
JP2005514323A (ja) 2005-05-19
AR036018A1 (es) 2004-08-04
CA2447673A1 (en) 2002-11-28
EP1395588A2 (en) 2004-03-10
KR20040010649A (ko) 2004-01-31
US20040242865A1 (en) 2004-12-02
MXPA03010548A (es) 2004-05-27
HUP0501093A2 (en) 2006-03-28
ZA200309288B (en) 2005-02-28
BR0209844A (pt) 2005-04-05
NO20035137D0 (no) 2003-11-18

Similar Documents

Publication Publication Date Title
CA2601129C (en) Crystallisation and purification of glycopyrronium bromide
US7332600B2 (en) Process for the preparation of crystalline imipenem
MX2011009532A (es) Metodo mejorado para preparar meropenem usando polvo de zinc.
OA12608A (en) Process for the isolation of crystalline imiponem.
KR100364339B1 (ko) 안정화된 카바페넴 중간체 및 합성적 용도
CA2461565C (en) Process for making carbapenem compounds
US7078534B2 (en) Process for the preparation of crystalline N-formimidoyl thienamycin monohydrate (imipenem monohydrate)
ES2328117T3 (es) Proceso para la preparacion de imipenem.
AU2002302887A1 (en) Process for the isolation of crystalline imipenem
CN100383142C (zh) 一种制备亚胺培南的方法
WO2012081033A2 (en) A process for preparation of imipenem
KR20130028203A (ko) 무정형 도리페넴·일수화물의 제조방법
AU2002347451A1 (en) Process for the preparation of crystalline imipenem
EP0883620A1 (en) Process for the preparation of 2-halomethyl-penems and their use for the preparation of antibacterial penems
AU2002302882A1 (en) Process for the preparation of imipenem
KR19980082654A (ko) 세푸록심 에스테르 유도체의 제조방법